Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort study
Key Points
Changes in SUV after treatment do not reliably predict survival outcomes in cervical cancer, indicating limitations in using this marker.
Analysis involved a retrospective cohort of patients with locally advanced cervical cancer treated with radiation therapy.
SUV changes observed in FDG-PET scans may not be suitable as standalone prognostic indicators, complicating treatment decisions.
Further validation is needed to explore the applicability of SUV changes in clinical settings, as this study shows potential inconsistency.
Abstract
Changes in SUV after treatment may not be a reliable stand-alone marker for predicting recurrence or survival in locally advanced cervical cancer after treatment with radiation therapy.